PedAM
Pediatric Disease Annotations & Medicines
| Disease | portal vein thrombosis |
| Phenotype | C0023890|liver cirrhosis |
| Sentences | 11 |
| PubMedID- 19864937 | Impact of antithrombin iii concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. |
| PubMedID- 19730112 | Background: treatment of portal vein thrombosis (pvt) in patients with liver cirrhosis is not well established. |
| PubMedID- 23637275 | Value of d-dimer and protein s for diagnosis of portal vein thrombosis in patients with liver cirrhosis. |
| PubMedID- 23700877 | Aim: to evaluate the incidence and risk factors for thrombotic events (deep vein thrombosis and portal vein thrombosis) in patients with liver cirrhosis. |
| PubMedID- 25701619 | Objective: we have compared the influences of three surgical strategies on the occurrence and development of portal vein thrombosis (pvt) in patients with liver cirrhosis complicated by portal hypertension (pht) in this study. |
| PubMedID- 25088236 | Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis. |
| PubMedID- 19686413 | Protein c and d-dimer are related to portal vein thrombosis in patients with liver cirrhosis. |
| PubMedID- 21310200 | There are indications that the risk for development of portal vein thrombosis in patients with advanced liver cirrhosis might be increased under therapy with thrombopoietin receptor agonists. |
| PubMedID- 24103282 | Risk factors and clinical characteristics of portal vein thrombosis after splenectomy in patients with liver cirrhosis. |
| PubMedID- 20530055 | Antiphospholipid antibodies and antiphospholipid syndrome: role in portal vein thrombosis in patients with and without liver cirrhosis. |
| PubMedID- 26513611 | Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. |
Page: 1